Guidance

Changes to this edition of the gynaecological cytopathology EQA scheme

Updated 7 April 2025

Applies to England

The EQA management board approved the following changes to the 12th edition of the NHS cervical screening programme (NHS CSP) gynaecological cytopathology EQA scheme.

References to 鈥榤anagement board鈥� have been removed and there is revised nomenclature for National QA Lead (now the Cervical Screening Senior Clinical Lead).

1. Introduction

Inserted a reference to the applicable ISO standard (17043).

2. Chapter 1 The EQA scheme

Section 1.3 EQA scheme enquiries 鈥� updated contact information.

3. Chapter 3 Governance

Removal of section 3.3 EQA Management Board.

Section 3.2 updated remit for EQA steering group.

4. Chapter 4 Laboratory participation

Section 4.2 enrolment of new laboratories to the scheme.

Inserted content relating to the enrolment of non-NHS laboratories and the levying of fees for participation.

5. Chapter 6 Preparation for EQA

Section 6.5 Assembly of slide sets.

Removed reference to the number of participants required for statistical validity.

6. Chapter 16 Referral sheet for reporting abnormal slides

New section 鈥� content (unchanged) previously accessed through a different page.

7. Chapter 17 Scoring matrices

New section 鈥� content (unchanged) previously accessed through a different page.

8. Chapter 18 Performance examples with action points

New section 鈥� content (unchanged) previously accessed through a different page.

9. Chapter 19 Amalgamation of grades when both adjacent grades have equal consensus

New section 鈥� content (unchanged) previously accessed through a different page.